Gene variants (ie, alleles or polymorphisms) that code for the enzymes responsible for drug metabolism

can Autophagy Compound Library affect pharmacokinetics, and therefore the amount of drug available in the bodyto elicit a response. In addition, gene variants can affect pharmacodynamics, the therapeutic effect of a drug in the target organ (Figure 1 , “PK and PD”). Representative examples in breast cancer research include the overexpression of the ITER2 gene, a positive predictor of response Inhibitors,research,lifescience,medical to the drug trastuzumab (Herceptin), and the predictive value of active cytochrome P450 (CYP) 2D6 alleles in tamoxifen discontinuation.3 Figure 1. The influence of pharmacokinetic, pharmacodynamic and environmental Inhibitors,research,lifescience,medical factors on pharmacotherapy response and side effects (source: www.silvermedia.ca). In psychiatry, we lack basic laboratory investigations to diagnose mental illness, let alone genetic advances to guide treatment. A primary goal of current research is to characterize the etiologies and biological susceptibilities of heterogeneous, complex conditions, such as depression and psychosis. We are at the threshold of being able to predict treatment response, primarilythrough genetics and neuroimaging. Personalized medicine in psychiatry is a broad topic. As such, we will confine our review Inhibitors,research,lifescience,medical to the most promising markers of treatment response and adverse effects emerging from the areas of pharmacogenetics

and neuroimaging in depression Inhibitors,research,lifescience,medical and schizophrenia. Genetics of antipsychotic drug metabolism, response, and side effects in schizophrenia Antipsychotic drugs remain the cornerstone of treatment in schizophrenia. However, more than 20% of patients do not initially respond to treatment with drug therapy.4 In addition to lack of response, many patients discontinue their medication due to side effects, which can have serious and devastating consequences.5 In the following sections we discuss the genetics of antipsychotic drug metabolism, response, and side effects in schizophrenia. Genetics of antipsychotic Inhibitors,research,lifescience,medical drag metabolism The vast majority of antipsychotic drugs are metabolized by

the liver enzymes CYP2D6 and CYP2C19, which play critical roles in determining plasma drug levels. Gene variants that confer altered enzymatic activity influence plasma drug levels, and therefore can predict effective drug doses and potential side effects. The CYP2D6 gene codes for an enzyme that is responsible for metabolizing the Thymidine kinase majority of antipsychotic medications.6 This enzyme shows genetic variability in activity and is highly polymorphic, with over 70 single nucleotide polymorphisms (SNPs) and copy number variations (CNVs).7 These variations can influence antipsychotic drug activity and a patient’s ability to metabolize them. Individuals can be classified, based on their gene polymorphisms, as poor (PM), intermediate (IM), extensive/normal (EM), or ultrarapid drug metabolizers (UM).